|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.35 INR | +1.65% |
|
+7.87% | -34.11% |
Concord Drugs Limited (BSE:538965) agreed to acquire 100% stake in Proton Remedies Private Limited for INR 14.2 million on September 7, 2022. The consideration will INR 283 per share in cash for 50,000 equity shares. Proton Remedies Private Limited generated turnover of INR 95.6 million for the year 2021-22.
Time period for completion of the acquisition is On or before March 31, 2023
| 1st Jan change | Capi. | |
|---|---|---|
| -34.11% | 4.65M | |
| +32.09% | 693B | |
| +29.39% | 584B | |
| -1.34% | 372B | |
| +20.34% | 332B | |
| +7.39% | 294B | |
| +14.25% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +8.49% | 168B |
CONCORD DRUGS LIMITED 
